TransBiotec, Inc.
TransBiotec, Inc. (IMLE) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 9 transactions totaling $1.1M, demonstrating a bullish sentiment with $1.1M in net insider flow. The most recent transaction on Feb 15, 2020 involved a purchase of 0 shares valued at $0.
IMLE Insider Activity Summary
Who Is Buying IMLE Stock?
No significant insider buying has been recorded for IMLE in the recent period.
Who Is Selling IMLE Stock?
No significant insider selling has been recorded for IMLE in the recent period.
Is TransBiotec, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IMLE is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
IMLE Frequently Asked Questions
Understanding IMLE Insider Activity
Insider trading at TransBiotec, Inc. (IMLE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading IMLE stock, having executed 9 transactions in the past 90 days. The most active insider is Charles Warren Bennington (Executive), who has made 1 transactions totaling $560.0K.
Related Tools
Track TransBiotec, Inc. Insider Activity
Get notified when executives and directors at IMLE file new Form 4 transactions